J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 68 (1987), 39-46; DOI 10.1099/0022-1317-68-1-39
© 1987 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inglis, M. M.
Right arrow Articles by Darby, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inglis, M. M.
Right arrow Articles by Darby, G.
Agricola
Right arrow Articles by Inglis, M. M.
Right arrow Articles by Darby, G.

Analysis of the Role of the Cysteine 171 Residue in the Activity of Herpes Simplex Virus Type 1 Thymidine Kinase by Oligonucleotide-directed Mutagenesis

Moira M. Inglis and Graham Darby{dagger}

Division of Virology, Department of Pathology, Cambridge University, Tennis Court Road, Cambridge CB2 1QP, U.K.

The thymidine kinase (TK) gene from herpes simplex virus type 1 strain SC16 was cloned into bacteriophage M13 mp8 so that functional HSV-1 TK was expressed in bacteria infected with the recombinant bacteriophage, M13/TK. Oligonucleotide site-directed mutagenesis was then employed to introduce single nucleotide changes into the TK gene in M13/TK in order to alter the codon for cysteine 171 in the wild-type enzyme to a codon specifying either serine or glycine. Analysis of the mutant enzymes in bacterial extracts showed that these substitutions had little effect on the activity of the enzyme, indicating that the side chain of this residue is not involved in nucleoside binding and is not essential for the catalytic activity of the enzyme.

{dagger} Present address: Department of Biochemical Virology, Wellcome Research Laboratories, Langley Court, Beckenham, Kent BR3 3BS, U.K.

Received 11 June 1986; accepted 19 September 1986.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1987 by the Society for General Microbiology.